Streetbeat News

Price Targets

EPR

Truist Securities analyst Ki Bin Kim has maintained a Hold rating on EPR Properties (NYSE:EPR) and reduced the price target from $50 to $49.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:57 pm

HURN

Truist Securities analyst Tobey Sommer has reaffirmed a Buy rating on Huron Consulting Group (NASDAQ:HURN) and increased the price target from $130 to $140.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:56 pm

BNL

Truist Securities analyst Ki Bin Kim has maintained a Hold rating on Broadstone Net Lease (NYSE:BNL) and reduced the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:52 pm

AVB

Truist Securities analyst Michael Lewis has maintained a Buy rating on AvalonBay Communities (NYSE:AVB) but has reduced the price target from $214 to $202.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:50 pm

ADC

Truist Securities analyst Ki Bin Kim has maintained a Buy rating on Agree Realty (NYSE:ADC) but has reduced the price target from $74 to $62.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:47 pm

DPZ

TD Cowen analyst Andrew Charles has reaffirmed an Outperform rating on Domino's Pizza (NYSE:DPZ) and increased the price target from $410 to $430, signaling confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:42 pm

TERN

Mizuho analyst Graig Suvannavejh has maintained a Buy rating on Terns Pharma (NASDAQ:TERN) but reduced the price target from $17 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:36 pm

NSTG

Canaccord Genuity analyst Kyle Mikson has maintained a Buy rating on NanoString Technologies (NSTG) but has reduced the price target from $5 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:32 pm

DE

Canaccord Genuity analyst Bobby Burleson has maintained a Hold rating on Deere & Company (NYSE:DE) but has reduced the price target from $400 to $375.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:29 pm

BSX

Canaccord Genuity analyst William Plovanic has maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the price target from $60 to $64.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 4:26 pm